Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.

• Автори: Saskia van Henten (Автор), Annisa Befekadu Tesfaye (Автор), Seid Getahun Abdela (Автор), Feleke Tilahun (Автор), Helina Fikre (Автор), Jozefien Buyze (Автор), Mekibib Kassa (Автор), Lieselotte Cnops (Автор), Myrthe Pareyn (Автор), Rezika Mohammed (Автор), Florian Vogt (Автор), Ermias Diro (Автор), Johan van Griensven (Автор)
• Формат: Книга
• Опубліковано: Public Library of Science (PLoS), 2021-05-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

<h4>Background</h4>Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely...